Education
About Us
Working with TipRanks
Follow Us
Advicenne SA (FR:ALDVI)
:ALDVI
ALDVI Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.92 - €2.38
Previous CloseN/A
Volume979.00
Average Volume (3M)81.70K
Market Cap
€22.33M
Enterprise Value€39.11M
Total Cash (Recent Filing)€3.25M
Total Debt (Recent Filing)€18.19M
Price to Earnings (P/E)―
Beta0.27
Next Earnings
Mar 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.40
Shares Outstanding14,219,619
10 Day Avg. Volume168,907
30 Day Avg. Volume81,697
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€1.00Price Target Upside-36.71% Downside
Rating ConsensusHold
Number of Analyst Covering0
Advicenne SA News
ALDVI FAQ
What was Advicenne SA’s price range in the past 12 months?
Advicenne SA lowest stock price was €0.92 and its highest was €2.38 in the past 12 months.
What is Advicenne SA’s market cap?
Advicenne SA’s market cap is €22.33M.
When is Advicenne SA’s upcoming earnings report date?
Advicenne SA’s upcoming earnings report date is Mar 26, 2026 which is in 178 days.
How were Advicenne SA’s earnings last quarter?
Advicenne SA released its earnings results on Sep 19, 2025. The company reported -€0.4 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.4.
Is Advicenne SA overvalued?
According to Wall Street analysts Advicenne SA’s price is currently Overvalued.
Does Advicenne SA pay dividends?
Advicenne SA does not currently pay dividends.
What is Advicenne SA’s EPS estimate?
Advicenne SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Advicenne SA have?
Advicenne SA has 14,219,619 shares outstanding.
What happened to Advicenne SA’s price movement after its last earnings report?
Advicenne SA reported an EPS of -€0.4 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.09%.
Which hedge fund is a major shareholder of Advicenne SA?
Currently, no hedge funds are holding shares in FR:ALDVI
Company Description
Advicenne SA
Advicenne SA (ALDVI) is a biopharmaceutical company specializing in the development and commercialization of innovative therapies for rare diseases, particularly those affecting pediatric patients. The company focuses on addressing unmet medical needs through its lead product, ADV7103, which is designed to treat primary hyperoxaluria type 1, a rare genetic disorder. Advicenne operates primarily in the healthcare sector, leveraging its expertise in drug development to enhance treatment options for patients with specific metabolic disorders.
Technical Analysis
Nicox SA
―
GenSight Biologics SA
―
Valbiotis SA
―
NFL Biosciences SA
―
Plant Advanced Technologies SA
―